What are my alternatives to knee replacement?
Compare nonsurgical knee arthritis care, injection choices, and selected surgical alternatives—with evidence, limits, and questions for your clinician.
Read the guide ↗Medically reviewed by Charles A. DeCook, MD ·
← All optionsLearn about the evidence
Collagen, fish oil & other blends
No antioxidant protocol. No house brand.
Who might it suit?
For: Reviewing collagen, MSM, fish oil, vitamin D, or antioxidant claims.
Not for: Treating OA with a vitamin when there is no deficiency.
Limits and important cautions
Collagen results do not validate MSM, antioxidant mixtures, or cartilage-regrowth claims. Treating a diagnosed deficiency is separate from treating OA.
What happens, how long, and what could it cost?
- What happens
- Review the precise ingredients and doses with a clinician or pharmacist, including interactions.
- When might I notice a change?
- A reliable personal timeline cannot be predicted from the evidence reviewed here. Agree on a review date before starting.
- How long might benefit last?
- Benefit and durability depend on the exact intervention and population. The evidence section below explains what is known.
- Repeat treatment
- Set a review point and avoid indefinite purchases without meaningful benefit.
- Activity and recovery
- Discuss interactions and whether the product should be paused around surgery.
- Ask for a complete estimate
- The exact formulation, ongoing purchases, and any monitoring.
Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.
THE EVIDENCE IN CONTEXT
Mixed evidence by ingredient
Read the 5 selected references
- Liang et al.: collagen derivatives for OA ↗
Found small-to-moderate average pain and function benefits. Symptom outcomes do not demonstrate regrowth of worn cartilage or validate every blend.
- Jin et al.: vitamin D for symptomatic knee OA ↗
Did not establish knee pain or cartilage-volume benefit. Correcting deficiency for bone health is a different clinical indication.
- ACR/Arthritis Foundation: OA management ↗
2019 guideline, published in 2020. Recommendations vary by joint; it predates many newer trials.
- MSM supplementation for knee OA ↗
A short trial reported some symptom improvements. Limited sample size and duration do not establish long-term safety or structural benefit.
- Hill et al.: high- versus low-dose fish oil ↗
No added benefit of high-dose over low-dose fish oil. The comparator contained other oil; this was not a placebo test of fish oil itself.
FDA status
Supplements · no disease-treatment approvalSupplements are not FDA-approved disease treatments.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.What do professional guidelines say?
ACR: Conditionally against fish oil and vitamin D as OA treatments.
Will Medicare cover it?
No routine OA supplement coverage.